Do patients on dialysis (hemodialysis) require more or less insulin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Requirements in Patients on Dialysis

Patients on hemodialysis require significantly less insulin compared to their pre-dialysis requirements, with recommended reductions of 35-50% in total daily insulin doses due to decreased insulin clearance and impaired gluconeogenesis. 1

Pathophysiology of Insulin Requirements in Dialysis

  • Patients with early CKD stages experience increased insulin resistance, requiring higher insulin doses, but as they progress to end-stage kidney disease (ESKD) and dialysis, they need substantially less insulin 1
  • The kidney normally clears 30-80% of insulin, so decreased kidney function in dialysis patients leads to reduced insulin clearance and prolonged insulin action 1
  • Several mechanisms contribute to hypoglycemia risk in dialysis patients:
    • Decreased gluconeogenesis by the kidneys 1
    • Impaired insulin clearance and reduced insulin degradation 1
    • Increased erythrocyte glucose uptake during hemodialysis 1
    • Impaired counterregulatory hormone responses 1
    • Nutritional deprivation common in dialysis patients 1

Specific Insulin Dose Adjustments for Dialysis Patients

  • For patients with type 1 diabetes on dialysis: reduce total daily insulin dose by 35-40% 1
  • For patients with type 2 diabetes on dialysis: reduce total daily insulin dose by approximately 50% 1
  • Specifically for pre-hemodialysis days: reduce basal insulin dose by 25% 1, 2
  • Some patients (15-30%) with ESKD may experience "burn-out diabetes," requiring minimal or no insulin therapy 1, 2

Clinical Considerations and Monitoring

  • Hemodialysis itself can remove insulin, with studies showing significant decreases in plasma insulin levels during passage through the dialyzer 3
  • Glucose levels typically decrease significantly (up to 35.8%) during hemodialysis sessions 4
  • Continuous glucose monitoring is recommended for dialysis patients to detect asymptomatic and nocturnal hypoglycemia 1
  • HbA1c is less reliable in dialysis patients due to decreased red blood cell lifespan and anemia 2

Practical Approach to Insulin Management

  • For insulin-naive dialysis patients or those on low doses, start with 0.3-0.5 units/kg/day 1
  • For patients already on higher insulin doses (≥0.6 units/kg/day), reduce the total daily dose by 20% when hospitalized 1
  • Consider switching from NPH insulin to insulin glargine, which has been shown to improve glycemic control and reduce hypoglycemic episodes in hemodialysis patients 5
  • For peritoneal dialysis patients, insulin requirements may actually increase due to glucose absorption from dialysate, with each additional 2.5% 2L exchange potentially requiring 7.5 additional units of insulin per day 6

Hypoglycemia Prevention

  • Monitor blood glucose more frequently on dialysis days and the day after 2
  • Consider using a basal-plus approach rather than basal-bolus insulin regimens to minimize hypoglycemia risk 1
  • Target more moderate fasting blood glucose levels (110-130 mg/dL) rather than aggressive targets 2
  • Be vigilant for signs and symptoms of hypoglycemia, which may be more common and more dangerous in dialysis patients 2

Remember that insulin requirements in dialysis patients follow a biphasic course - increasing in early CKD but significantly decreasing in advanced CKD and dialysis - making careful dose adjustments essential to prevent dangerous hypoglycemic episodes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Type 2 Diabetes in Patients on Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2007

Research

Increased subcutaneous insulin requirements in diabetic patients recently commenced on peritoneal dialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.